K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

J.M. Ostrem, Ulf Peters(Howard Hughes Medical Institute), Martin L. Sos(University of California, San Francisco), James A. Wells(University of California, San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute)
Nature
November 1, 2013
10.1038/nature12796
Cited by 2,483Open Access
Full Text

Abstract

Related Papers

A Cytoplasmic Protein Stimulates Normal N- <i>ras</i> p21 GTPase, But Does Not Affect Oncogenic Mutants
Meg Trahey, Frank McCormick|Science|1987|1.2k
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Simon Forbes, Gurpreet Bhamra, Sally Bamford et al.|Current Protocols in Human Genetics|2008|918
Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation
E.F. Pai, Wolfgang Kabsch, Ute Krengel et al.|Nature|1989|889
Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.
W. Wayt Gibbs, Irving S. Sigal, Martin Poe et al.|Proceedings of the National Academy of Sciences|1984|616
Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated Activation
Qi Sun, Jason P. Burke, Jason Phan et al.|Angewandte Chemie International Edition|2012|499